Search Results for: stem cell biotech

Therapeutic misconception & the planned Duke Cryo-Cell cord clinic

Duke Cryo-Cell therapeutic misconception

One of the core problems in the world of unproven stem cell clinics is something called therapeutic misconception. I’ll talk more about that in a minute, but first, let me tell you what brought this to mind now. Surprisingly, the story starts at Duke University. A Duke cell therapy team and the biotech Cryo-Cell have big […]

Therapeutic misconception & the planned Duke Cryo-Cell cord clinic Read More »

Clade Therapeutics pursues universal cells for cancer therapy

Chad-Cowan CRISPR Therapeutics

Clade  Therapeutics has been pursuing the idea of using gene-editing to make universally compatible cells. The potential here is big. What if you could make cloaked stem cells that could be used to produce cellular therapies that could be given to most patients without fear of immune rejection? Clade Therapeutics Boston Business Journal covers the

Clade Therapeutics pursues universal cells for cancer therapy Read More »

Weekly stem cell reads: pending FDA verdict, blood vessels, RA

Cellular populations in the vascular wall, stem cell niche

Any day now we should get the verdict from the judge in the big stem cell clinic case here in California against Cell Surgical Network, et al. It seems that the FDA is waiting on this verdict before taking some major actions. If the judge rules against the agency it could throw the area into

Weekly stem cell reads: pending FDA verdict, blood vessels, RA Read More »

Vertex upbeat on 1st stem cell therapy for diabetes trial participant

“While still early, these results support the continued progression of our VX-880 clinical studies, as well as future studies using our encapsulated islet cells, which hold the potential to be used without the need for immunosuppression,” said Bastiano Sanna, Ph.D., executive vice president and chief of cell and genetic therapies at Vertex.

It’s hard in the cell therapy field not to get excited even with bits of seemingly encouraging news but with N=1 reports we have to be very cautious and that’s the case with news from Vertex on their 1st stem cell therapy for diabetes trial participant. Vertex stem cell therapy for diabetes VX-880: N=1 This

Vertex upbeat on 1st stem cell therapy for diabetes trial participant Read More »

Vice tackles dicey Cryo-Cell Duke mega-million peds clinic plan

stem cells for autism

When I first learned about the multi-$10 million cord cell clinic deal between Duke and Cryo-Cell I couldn’t believe what I was reading. Duke’s involved in this? The problem: marketing unproven cells for kids Yes, this wasn’t some stem cell clinic operating out of a strip mall seeking to make big money off of injecting

Vice tackles dicey Cryo-Cell Duke mega-million peds clinic plan Read More »

Weekly reads: Bezos & stem cells for anti-aging, Myc, more

young blood, stem cells anti-aging

Stem cells may have anti-aging properties, but they are unlikely to be a real fountain of youth. Even so, people are obsessed with aging and stem cells regularly are thought of as “the ticket” for fighting aging. I’ll start today’s recommended reads with that topic and then go on to list some interesting papers of

Weekly reads: Bezos & stem cells for anti-aging, Myc, more Read More »

Congrats to Lusubilo Mwalilino, the winner of our stem cell video contest

Lusubilo Mwalilino, the winner of our stem cell video contest

Every year I run a number of contests here on The Niche and the most recent is a stem cell video contest.   I’m pleased to announce the winner of our contest is Lusubilo Mwalilino. You can see her video entry above, which is now part of our stem cell YouTube channel. Please check out

Congrats to Lusubilo Mwalilino, the winner of our stem cell video contest Read More »

FDA should freeze Duke EAP & probe $58 million Cryo-Cell deal linked to it

cryo cell infusion clinic marketing

I recently found concerning SEC filings from the biotech Cryo-Cell about a deal it has with a Duke team for infusions of children with unproven umbilical cord cells. This turns out to be a $58 million deal. It relates in a major way to a Duke compassionate use or expanded access program (EAP) that already had raised

FDA should freeze Duke EAP & probe $58 million Cryo-Cell deal linked to it Read More »